JP Morgan Maintains Overweight on Sempra, Raises Price Target to $106

Benzinga Newsdesk www.benzinga.com Positive 79.3%

Neg 0% Neu 0% Pos 79.3%

JP Morgan analyst Christopher Turnure maintains Sempra (NYSE:SRE) with a Overweight and raises the price target from $98 to $106.